MedTrace Logo

Effectiveness of Individualized Automatic Coaching Message for Glycemic Management and Depressive Symptom

NCT06769906 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 46

Last updated 2026-01-02

No results posted yet for this study

Summary

This is a 12-week, single-center, randomized, prospective, confirmatory study of effectiveness of the individualized automatic coaching messages for glycemic management based on continuous glucose monitoring and depressive symptom in insulin-treated patients with type 2 diabetes.

Conditions

  • Diabetes Mellitus Type 2
  • Continuous Glucose Measurement
  • Depressive Symptom

Interventions

OTHER

Individualized automatic coaching message for glycemic management and depressive symptom

For 12 weeks, the intervention group will apply continuous glucose monitoring system and receive weekly personalized coaching messages for glycemic management based on data from continuous glucose monitoring and bi-weekly personalized coaching messages for depression symptoms based on depression questionnaires.

Sponsors & Collaborators

  • Samsung Medical Center

    lead OTHER

Principal Investigators

  • GYURI KIM · Samsung Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-01-09
Primary Completion
2025-07-02
Completion
2025-07-02

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06769906 on ClinicalTrials.gov